Tiber Creek Group is a lobbying arm working on behalf of Merck & Co., a major company that makes prescription medicines, vaccines, and biological therapies. The filings show it lobbied Congress mainly about drug pricing and pharmacy issues, including monitoring how drug pricing was handled in a recent federal bill (PL 119-21) and matters affecting Medicare and Medicaid. It hired outside firm B Hall Strategies for this work.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr JAMES BRYANT HALL ii
The latest disclosures for this client.
B HALL STRATEGIES, LLC
Q2B HALL STRATEGIES, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
B HALL STRATEGIES, LLC
B HALL STRATEGIES, LLC
Q4B HALL STRATEGIES, LLC
Q3B HALL STRATEGIES, LLC
Q2B HALL STRATEGIES, LLC
RR